Skip to content

Clininical efficacy evaluation of “Commiphora Mukul” on hemmorhoidal disease.

Explanation of hemmorhoidal disease in Iranian traditional medicine and clininical efficacy evaluation of “Commiphora Mukul” on it.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201111027976N1
Enrollment
80
Registered
2011-11-20
Start date
2011-11-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorroids. Internal haemorrhoids without complication

Interventions

Intervention 1: Patients with eligible criteria will be assigned in two groups. The 1st (intervention) group will take 3 g encapsulated puer Mukul daily in three divided doses after meal. Intervention
Treatment - Drugs
Patients with eligible criteria will be assigned in two groups. The 1st (intervention) group will take 3 g encapsulated puer Mukul daily in three divided doses after meal.
The other(control) group will receive antihemorrhoid suppository(single dose befoer sleeping for ten nights) and Lactolose(in a dose that makes defication easily).

Sponsors

Shahed University - Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: grade1 and 2 of hemorrhoids; age 25-65. Exclusion criteria: history of vascular accident; complicated hemorrhoids; pregnancy and lactation; active gastrointestinal bleeding ; any drug using; history of other anal diseases. Drop out criteria:pregnancy; drug intolerance occurrence; reluctance to continue project; incorrect drug taking;intolerable drug side effects;acute hemorrhoids complication occurrence

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Rectal bleeding. Timepoint: Before and after the intervention. Method of measurement: Questionnaire.;Anal prolapse. Timepoint: Before and after the intervention. Method of measurement: Clinical examination.

Secondary

MeasureTime frame
Side effects. Timepoint: Before and after the study. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Yousefi

Shahed university

Yousefim5@mums.ac.ir+98 21 8896 3849

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026